339 related articles for article (PubMed ID: 26405700)
41. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis.
Kevans D; Waterman M; Milgrom R; Xu W; Van Assche G; Silverberg M
J Gastroenterol Hepatol; 2015 Jan; 30(1):64-70. PubMed ID: 25041458
[TBL] [Abstract][Full Text] [Related]
42. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
[TBL] [Abstract][Full Text] [Related]
43. Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
Khalili H; Neovius M; Ekbom A; Ludvigsson JF; Askling J; Chan AT; Olen O
Am J Gastroenterol; 2016 Nov; 111(11):1614-1620. PubMed ID: 27725646
[TBL] [Abstract][Full Text] [Related]
44. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort.
Targownik LE; Singh H; Nugent Z; Bernstein CN
Am J Gastroenterol; 2012 Aug; 107(8):1228-35. PubMed ID: 22613902
[TBL] [Abstract][Full Text] [Related]
45. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
[TBL] [Abstract][Full Text] [Related]
46. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
Feagan BG; Sandborn WJ; Lazar A; Thakkar RB; Huang B; Reilly N; Chen N; Yang M; Skup M; Mulani P; Chao J
Gastroenterology; 2014 Jan; 146(1):110-118.e3. PubMed ID: 24067881
[TBL] [Abstract][Full Text] [Related]
47. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
[TBL] [Abstract][Full Text] [Related]
48. Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.
Burisch J; Katsanos KH; Christodoulou DK; Barros L; Magro F; Pedersen N; Kjeldsen J; Vegh Z; Lakatos PL; Eriksson C; Halfvarson J; Fumery M; Gower-Rousseau C; Brinar M; Cukovic-Cavka S; Nikulina I; Belousova E; Myers S; Sebastian S; Kiudelis G; Kupcinskas L; Schwartz D; Odes S; Kaimakliotis IP; Valpiani D; D'Incà R; Salupere R; Chetcuti Zammit S; Ellul P; Duricova D; Bortlik M; Goldis A; Kievit HAL; Toca A; Turcan S; Midjord J; Nielsen KR; Andersen KW; Andersen V; Misra R; Arebi N; Oksanen P; Collin P; de Castro L; Hernandez V; Langholz E; Munkholm P;
J Crohns Colitis; 2019 Feb; 13(2):198-208. PubMed ID: 30289522
[TBL] [Abstract][Full Text] [Related]
49. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study.
Sulz MC; Siebert U; Arvandi M; Gothe RM; Wurm J; von Känel R; Vavricka SR; Meyenberger C; Sagmeister M;
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):790-7. PubMed ID: 23571609
[TBL] [Abstract][Full Text] [Related]
50. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
[TBL] [Abstract][Full Text] [Related]
51. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
Bernstein CN; Nabalamba A
Am J Gastroenterol; 2006 Jan; 101(1):110-8. PubMed ID: 16405542
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
[TBL] [Abstract][Full Text] [Related]
53. Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease.
Nissen LH; Assendorp EL; van der Post RS; Derikx LA; de Jong DJ; Kievit W; Pierik M; van den Heuvel T; Verhoeven R; Overbeek LI; Hoentjen F; Nagtegaal ID
J Gastrointestin Liver Dis; 2016 Dec; 25(4):431-440. PubMed ID: 27981298
[TBL] [Abstract][Full Text] [Related]
54. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.
Hoie O; Wolters FL; Riis L; Bernklev T; Aamodt G; Clofent J; Tsianos E; Beltrami M; Odes S; Munkholm P; Vatn M; Stockbrügger RW; Moum B;
Gastroenterology; 2007 Feb; 132(2):507-15. PubMed ID: 17258717
[TBL] [Abstract][Full Text] [Related]
55. Predictors and risks for death in a population-based study of persons with IBD in Manitoba.
Bernstein CN; Nugent Z; Targownik LE; Singh H; Lix LM
Gut; 2015 Sep; 64(9):1403-11. PubMed ID: 25227522
[TBL] [Abstract][Full Text] [Related]
56. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
57. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.
Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S
J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770
[TBL] [Abstract][Full Text] [Related]
58. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
[TBL] [Abstract][Full Text] [Related]
59. Long term course of ulcerative colitis in the prebiologic era. A retrospective study in a tertiary referral center.
Margagnoni G; Fascì Spurio F; Feigusch L; Koch M; Papi C; Aratari A
Minerva Gastroenterol Dietol; 2014 Dec; 60(4):275-83. PubMed ID: 25384806
[TBL] [Abstract][Full Text] [Related]
60. Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis.
Samuel S; Ingle SB; Dhillon S; Yadav S; Harmsen WS; Zinsmeister AR; Tremaine WJ; Sandborn WJ; Loftus EV
Inflamm Bowel Dis; 2013 Aug; 19(9):1858-66. PubMed ID: 23660997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
